by Gordon Hensley | Jun 28, 2023 | Business, Management |
Client conference calls — whether video or audio — are a fact of life. But there are several things I dislike and, in my opinion, reflect very poorly on the group leader. Let’s start here: 1 — 60 minute calls. If the collective group cannot...
by Gordon Hensley | Aug 11, 2021 | Business, Communications, Management |
First things first: Zoom calls are great — with amazing utility and usefulness. As a means of bringing teams together virtually as COVID continues to hinder in-office meetings, Zoom is the most revolutionary technological tool to be developed and widely embraced...
by Gordon Hensley | Feb 23, 2021 | advocacy, Business, Campaign 2020, CDC, CMS, COVID, health care, HHS, Media Relations, Pharmaceutical, SNF, state government, Trump
Kudos to CBS Face the Nation moderator Margaret Brennan for her excellent interview of former Trump Administration Deputy National Security Advisor, Matthew F. Pottinger, surrounding several facets of the Trump Administration’s COVID-19 response. The discussion...
by Gordon Hensley | Apr 11, 2020 | advocacy, Business, lobbying, polling
With the onset of the COVID-19 pandemic, DC consultants, lobbyists, data specialists and others are scrambling for their lives, and indeed, their very livelihoods. Clients representing both vast sectors as well as smaller sub-sectors of the U.S. economy are shelling...
by Gordon Hensley | Oct 28, 2019 | advocacy, Business, GOP Politics, health care, Health Reform
As a Republican and admitted ideologue when it comes to assigning blame to “big government” and “regulatory overreach” for many of the nation’s ills, Axios points out today that, “Private equity firms don’t just own physician...
by Gordon Hensley | Jun 18, 2019 | advocacy, Business, CMS, health care, Medicaid funding, Pharmaceutical, state government
With pharmacy benefit managers (PBMs) under a cloud of their own making due to a business model wholly dependent upon opaque, non-transparent drug pricing practices, the Centers for Medicare and Medicaid Services (CMS) recently prohibited yet another controversial PBM...